Literature DB >> 21376099

(Neuro)inflammation and neuroprogression as new pathways and drug targets in depression: from antioxidants to kinase inhibitors.

Michael Maes, Brian Leonard, Alberto Fernandez, Marta Kubera, Gabriel Nowak, Rob Veerhuis, Ann Gardner, Piaynuj Ruckoanich, Michel Geffard, Carlo Altamura, Piotr Galecki, Michael Berk.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21376099     DOI： 10.1016/j.pnpbp.2011.02.019

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN： 0278-5846            Impact factor:   5.067


× No keyword cloud information.
  30 in total

Review 1.  Antioxidants as antidepressants: fact or fiction?

Authors:  Giovanni Scapagnini; Sergio Davinelli; Filippo Drago; Antonino De Lorenzo; Giovannangelo Oriani
Journal:  CNS Drugs       Date:  2012-06-01       Impact factor: 5.749

2.  Prognostic Significance of Depressive Symptoms on Weight Loss and Psychosocial Outcomes Following Gastric Bypass Surgery: A Prospective 24-Month Follow-Up Study.

Authors:  Marney A White; Melissa A Kalarchian; Michele D Levine; Robin M Masheb; Marsha D Marcus; Carlos M Grilo
Journal:  Obes Surg       Date:  2015-10       Impact factor: 4.129

Review 3.  New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates--Nrf2 activators and GSK-3 inhibitors.

Authors:  Michael Maes; Zdenĕk Fišar; Miguel Medina; Giovanni Scapagnini; Gabriel Nowak; Michael Berk
Journal:  Inflammopharmacology       Date:  2012-01-24       Impact factor: 4.473

Review 4.  New Directions in Treatments Targeting Stroke Recovery.

Authors:  David J Lin; Seth P Finklestein; Steven C Cramer
Journal:  Stroke       Date:  2018-12       Impact factor: 7.914

Review 5.  Viral infection, inflammation and schizophrenia.

Authors:  Rachel E Kneeland; S Hossein Fatemi
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2012-02-10       Impact factor: 5.067

6.  Toward Prevention of Mild Cognitive Impairment in Older Adults With Depression: An Observational Study of Potentially Modifiable Risk Factors.

Authors:  Damien Gallagher; Alex Kiss; Krista L Lanctot; Nathan Herrmann
Journal:  J Clin Psychiatry       Date:  2018-11-27       Impact factor: 4.384

7.  Malondialdehyde plasma concentration correlates with declarative and working memory in patients with recurrent depressive disorder.

Authors:  Monika Talarowska; Piotr Gałecki; Michael Maes; Ann Gardner; Marcelina Chamielec; Agata Orzechowska; Kinga Bobińska; Edward Kowalczyk
Journal:  Mol Biol Rep       Date:  2011-12-15       Impact factor: 2.316

8.  Dysregulated relationship of inflammation and oxidative stress in major depression.

Authors:  B J Rawdin; S H Mellon; F S Dhabhar; E S Epel; E Puterman; Y Su; H M Burke; V I Reus; R Rosser; S P Hamilton; J C Nelson; O M Wolkowitz
Journal:  Brain Behav Immun       Date:  2012-11-29       Impact factor: 7.217

Review 9.  Drugs to Enhance Motor Recovery After Stroke.

Authors:  Steven C Cramer
Journal:  Stroke       Date:  2015-08-11       Impact factor: 7.914

Review 10.  Possible Hepatoprotective Effect of Tocotrienol-Rich Fraction Vitamin E in Non-alcoholic Fatty Liver Disease in Obese Children and Adolescents.

Authors:  Farah D R Al-Baiaty; Aziana Ismail; Zarina Abdul Latiff; Khairul Najmi Muhammad Nawawi; Raja Affendi Raja Ali; Norfilza Mohd Mokhtar
Journal:  Front Pediatr       Date:  2021-07-08       Impact factor: 3.418
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.